Cargando…

Screening and Identification of Biomarkers in Ascites Related to Intrinsic Chemoresistance of Serous Epithelial Ovarian Cancers

OBJECTIVE: The ability to predict responses to chemotherapy for serous epithelial ovarian cancer (EOC) would be valuable since intrinsically chemoresistant EOC patients (persistent or recurrent disease within 6 months) gain little benefit from standard chemotherapy. The aim of this study was to scre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, He, Li, Yujie, Liu, Jihong, Zheng, Minghui, Feng, Yanling, Hu, Kunhua, Huang, Yongwen, Huang, Qidan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519621/ https://www.ncbi.nlm.nih.gov/pubmed/23251472 http://dx.doi.org/10.1371/journal.pone.0051256

Ejemplares similares

Ascitic Senescent T Cells Are Linked to Chemoresistance in Patients With Advanced High-Grade Serous Ovarian Cancer
por: Zhang, Jie, et al.
Publicado: (2022)

Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers
por: Lane, Denis, et al.
Publicado: (2015)

The impact of lymph node dissection on survival in patients with clinical early-stage ovarian cancer
por: Deng, Ting, et al.
Publicado: (2021)

A single-cell landscape of pre- and post-menopausal high-grade serous ovarian cancer ascites
por: Chen, Wenying, et al.
Publicado: (2023)

GOLPH3L is a Novel Prognostic Biomarker for Epithelial Ovarian Cancer
por: Feng, Yanling, et al.
Publicado: (2015)

Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer
por: Kim, Soochi, et al.
Publicado: (2018)

Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer
por: Feng, Li-yuan, et al.
Publicado: (2021)

NANOG regulates epithelial–mesenchymal transition and chemoresistance in ovarian cancer
por: Qin, Shan, et al.
Publicado: (2017)

Soluble osteopontin concentrations in serum and ascites of women with advanced serous ovarian cancer
por: Černe, Katarina, et al.
Publicado: (2012)

Identification of Prognosis Biomarkers for High-Grade Serous Ovarian Cancer Based on Stemness
por: Wang, Zhihang, et al.
Publicado: (2022)

Epigenetic Mechanisms and Therapeutic Targets in Chemoresistant High-Grade Serous Ovarian Cancer
por: Matthews, Bayley G., et al.
Publicado: (2021)

FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells
por: Chiu, Wen-Tai, et al.
Publicado: (2014)

Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors
por: Latifi, Ardian, et al.
Publicado: (2012)

Identification of Chemoresistance-Associated Key Genes and Pathways in High-Grade Serous Ovarian Cancer by Bioinformatics Analyses
por: Wu, Yong, et al.
Publicado: (2020)

Low initial human papillomavirus viral load may indicate worse prognosis in patients with cervical carcinoma treated with surgery
por: Deng, Ting, et al.
Publicado: (2015)

Prognostic and Safety Roles in Laparoscopic Versus Abdominal Radical Hysterectomy in Cervical Cancer: A Meta-analysis
por: Cao, Tiefeng, et al.
Publicado: (2015)

A novel combination of niraparib and anlotinib in platinum-resistant ovarian cancer: Efficacy and safety results from the phase II, multi-center ANNIE study
por: Liu, Guochen, et al.
Publicado: (2022)

High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma
por: Cheng, W-F, et al.
Publicado: (2009)

DNA Repair Protein HELQ and XAB2 as Chemoresponse and Prognosis Biomarkers in Ascites Tumor Cells of High-Grade Serous Ovarian Cancer
por: Zhu, Fang, et al.
Publicado: (2022)

Leptin contributes to the taxol chemoresistance in epithelial ovarian cancer
por: Gu, Fei, et al.
Publicado: (2019)

Dysregulation of lnc-SNHG1 and miR-216b-5p correlate with chemoresistance and indicate poor prognosis of serous epithelial ovarian cancer
por: Pei, Mei Li, et al.
Publicado: (2020)

Adipocytes promote ovarian cancer chemoresistance
por: Yang, Jiang, et al.
Publicado: (2019)

DNA methylation and transcriptomic features are preserved throughout disease recurrence and chemoresistance in high grade serous ovarian cancers
por: Gull, Nicole, et al.
Publicado: (2022)

Role of perigastric arcade removal in serous epithelial ovarian cancers
por: Kulkarni, Rohini Vinayak, et al.
Publicado: (2023)

BDP1 as a biomarker in serous ovarian cancer
por: Cabarcas‐Petroski, Stephanie, et al.
Publicado: (2022)

MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer
por: Silasi, Dan-Arin, et al.
Publicado: (2007)

Expression of RET finger protein predicts chemoresistance in epithelial ovarian cancer
por: Horio, Maiko, et al.
Publicado: (2012)

Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress
por: Ip, Carman K. M., et al.
Publicado: (2016)

Chemoresistance is associated with Beclin-1 and PTEN expression in epithelial ovarian cancers
por: YING, HUANCHUN, et al.
Publicado: (2015)

Overexpression of Cathepsin L is associated with chemoresistance and invasion of epithelial ovarian cancer
por: Sui, Hongying, et al.
Publicado: (2016)

Molecular Profiling and Clinical Outcome of High-Grade Serous Ovarian Cancer Presenting with Low- versus High-Volume Ascites
por: Feigenberg, Tomer, et al.
Publicado: (2014)

Identifying ITGB2 as a Potential Prognostic Biomarker in Ovarian Cancer
por: Li, Chanyuan, et al.
Publicado: (2023)

Revisiting chemoresistance in ovarian cancer: Mechanism, biomarkers, and precision medicine
por: Guo, Chong, et al.
Publicado: (2020)

Identification of an Individualized Prognostic Biomarker for Serous Ovarian Cancer: A Qualitative Model
por: Luo, Fengyuan, et al.
Publicado: (2022)

Ascites-derived CDCP1+ extracellular vesicles subcluster as a novel biomarker and therapeutic target for ovarian cancer
por: Kong, Lingnan, et al.
Publicado: (2023)

Cytology of peritoneal implants of borderline serous tumor of ovaries in ascitic fluid
por: Sharma, Sudha, et al.
Publicado: (2021)

Ascites-Derived Organoids to Depict Platinum Resistance in Gynaecological Serous Carcinomas
por: Arias-Diaz, Andrea Estrella, et al.
Publicado: (2023)

The Role of GOLPH3L in the Prognosis and NACT response in Cervical Cancer
por: Feng, Yanling, et al.
Publicado: (2017)

Molecular Subtyping of Serous Ovarian Tumors Reveals Multiple Connections to Intrinsic Breast Cancer Subtypes
por: Jönsson, Jenny-Maria, et al.
Publicado: (2014)

MicroRNA let-7g acts as tumor suppressor and predictive biomarker for chemoresistance in human epithelial ovarian cancer
por: Biamonte, Flavia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n72cj7o7fngatfqp350qof7rb5